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The Pritzker School of Medicine, University of Chicago, Chicago, 
U.S.A. 
1. Introduction 
Breast cancer is the most frequently diagnosed form of cancer among women. Breast cancer 
is the leading cause of cancer death in nearly all developed countries, showing an increased 
incidence over the last decades, and the expected number of new U.S. patients in 2010 
would be 209,060, and the death number will be 40,230 1. The clinical management of breast 
cancer invariably involves diverse conventional modalities, including surgery, 
chemotherapy, and radiation 2. The complex characteristics of breast cancer may also require 
some alternative management to improve the therapeutic efficacy of conventional treatment 
and the quality of life for cancer patients 3.  
American ginseng (Panax quinquefolius L.) is a commonly used herb in the United States 
which belongs to the genus Panax L. in family Araliaceae 4. Panax is a small genus, and 
nearly all species in this genus are important herbal medicines, especially Asian ginseng 
(Panax ginseng C. A. Meyer) 5. Since Asian ginseng has been used as herbal medicine for a 
long history in oriental countries, many studies have been conducted on its constituents and 
its pharmacological effects 6. Asian ginseng has many reported health benefits including 
anticancer activities 7-9. In the 1990s, a case-control study on over a thousand Korean subjects 
showed that long-term ginseng consumption was associated with a decreased risk for many 
different cancers compared with those who did not consume ginseng 10,11. In contrast to 
many studies on Asian ginseng’s anticancer effects, investigation of American ginseng is 
limited 7, and its mechanisms of action are largely unknown.  
American ginseng extracts were found to inhibit the growth of breast cancer cells12. We 
previously investigated the effects of several herbal extracts on reducing chemotherapeutic 
side effects and found that American ginseng can attenuate cisplatin-induced nausea and 
vomiting in a rat model, while not affecting its anticancer properties in human cancer cells13. In 
addition, the extract from American ginseng enhanced the antiproliferation effect of cisplatin 
on human breast cancer cells, suggesting that it possesses its own anticancer activity13.  
In Asia, ginseng root is air-dried into white ginseng or steamed at 100 °C to give red 
ginseng. It is believed that red ginseng is more pharmacologically effective than white 
ginseng 14. The differences in the biological effects of white and red Asian ginseng are 
attributed to the significant changes in ginsenosides from the steaming treatment 15. In this 
study, we treated American ginseng root at various temperatures and heating times. After 
heat-processing, the root of American ginseng, like Asian ginseng, changes from white to 
red; steamed P. quinquefolius root is therefore referred to as red American ginseng.  
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Currently, the most popular herbal products are in extract forms. New regulations released 
by FDA on alternative complementary supplements require the botanical extracts to be 
standardized 16. The contents of ginsenosides in the extracts were not assayed before. We 
treated American ginseng root at various temperatures and heating times. The contents of 
representative ginsenosides in unsteamed and steamed American ginseng root extracts were 
determined using HPLC. In addition to the cell line MCF-7, we also used the MDA-MB-230 
human breast cancer cells to evaluate the chemopreventive activities of unsteamed and 
steamed American ginseng root extracts and four ginsenosides. To observe the anticancer 
mechanisms, the effects of American ginseng extracts and single compounds on apoptosis 
and cell cycle were evaluated.  
2. Materials and methods 
2.1 Chemicals 
All solvents were of high-performance liquid chromatography (HPLC) grade from Fisher 
Scientific (Norcross, GA). Milli Q water was supplied by a water purification system (US 
Filter, Palm Desert, CA). Standards for ginsenosides Rb1, Rb2, Rc, Rd, Re, and Rg1 were 
obtained from Indofine Chemical Company (Somerville, NJ); ginsenosides Rb3, Rg2, Rg3, 
Rh1, Rh2 and 20(R)-ginsenoside Rg2 (20R-Rg2) were obtained from the Delta Information 
Center for Natural Organic Compounds (Xuancheng, Anhui, China). All standards were of 
biochemical-reagent grade and at least 95% pure as confirmed by HPLC. All the plastic 
materials were purchased from Falcon Labware (Franklin Lakes, NJ). Trypsin, RPMI 1640 
medium, fetal bovine serum (FBS), and penicillin/streptomycin solution (200×) were 
obtained from Mediatech, Inc. (Herndon, VA). A CellTiter 96 Aqueous One Solution Cell 
Proliferation Assay kit was obtained from Promega (Madison, WI). Annexin V-FITC, cyclin 
A-FITC and cyclin D1-FITC were obtained from BD Biosciences (San Diego, CA).  
2.2 Plant materials, processing and extraction 
American ginseng roots (Panax quinquefolius L.) were obtained from Roland Ginseng, LLC 
(Wausau, WI). The voucher samples were deposited at the Tang Center for Herbal Medicine 
Research at University of Chicago (Chicago, IL). For the heat-processing of American ginseng, 
the roots were steamed at 100 °C and 120 °C for 1 h or at 120 °C for 0.5, 1, 2, 3, and 4 h. 
For the HPLC analysis, dried American ginseng sample (0.5 g) was extracted with methanol 
in a Soxhlet extractor for 8 h. The extract was concentrated, transferred into a 25-ml 
volumetric flask and diluted to the desired volume with methanol. One millimeter of the 
solution was purified by solid-phase extraction 17. Purified solutions were stored at 4 °C 
until HPLC analysis. 
For the in vitro anti-cancer studies, the process for the extraction of American ginseng 
samples was as follows: A root sample, unsteamed or steamed at various temperatures and 
times, was ground to powder and passed through a 40 mesh screen. Then 25 g of powder 
was extracted with 500 ml of 70% ethanol for 4 h; the water bath was maintained at 90 °C. 
When cooled, the solution was filtered with P8 filter paper (Fisher Scientific, Pittsburgh, PA) 
and the filtrate was collected. The residue was extracted with 500 ml of 70% ethanol once 
more and then filtered while the solution was cooled. The filtrates were combined and the 
solvent was evaporated under vacuum. The dried extract was dissolved in 100 ml water and 
then extracted with water-saturated n-butanol. The n-butanol phase was evaporated under 
vacuum and then lyophilized. 
The root of P. quinquefolius L. was collected from Roland Ginseng, LLC (Wausau, WI, USA).  
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2.3 HPLC analysis 
The HPLC system was a Waters 2960 instrument (Milford, MA) with a quaternary pump, an 
automatic injector, a photodiode array detector (Model 996), and Waters Millennium 32 
software for peak identification and integration. The separation was carried out on a 250×3.2 
mm i.d., 5μ, Ultrasphere C18 column (Alltech, Deerfield, IL) with a 7.5×3.2 mm i.d. guard 
column. For HPLC analysis, a 20-μL sample was injected into the column and eluted at 
room temperature with a constant flow rate of 1.0 ml/min. For the mobile phase, acetonitrile 
(solvent A) and water (solvent B) were used. Gradient elution started with 18% solvent A 
and 82% solvent B. Elution was changed to 21% A for 20 min, then to 26% A for 3 min and 
held for 19 min. It was then changed to 36% A for 13 min, to 50% A for 9 min, to 95% A for 2 
min, and held for 3 min. Lastly elution was changed to 18% A for 3 min and held for 8 min. 
The detection wavelength was set to 202 nm. All tested solutions were filtered through 
Millex 0.2-μm nylon membrane syringe filters (Millipore Co., Bedford, MA) before use. The 
linearity of this method was assayed by analyzing standard solutions in the range of 2-400 
μg/ml for the 12 ginsenosides. Calibration curves were constructed from the measured peak 
areas and the related amount of ginsenosides. Ginsenosides Rb1, Rb2, Rb3, Rc, Rd, Re, Rg1, 
Rg2, 20R-Rg2, Rg3, Rh1 and Rh2 (Figure 1) in extract samples were identified by comparison 
of their retention times with those obtained from the chromatograms of mixed ginsenoside 
standards. The contents of saponins in each sample were calculated using standard curves 
of ginsenosides. 
 
OH
R1O
R3O
R2
OR3
20(R)
20(S)
 
 
Name R1 R2 R3 
Ginsenoside Rb1 -glc2- 1glc -H 20(S), -glc6- 1glc 
Ginsenoside Rb2 -glc2- 1glc -H 20(S), -glc6- 1ara(pyr) 
Ginsenoside Rb3 -glc2- 1glc -H 20(S), -glc6- 1xyl 
Ginsenoside Rc -glc2- 1glc -H 20(S), -glc6- 1ara(fur) 
Ginsenoside Rd -glc2- 1glc -H 20(S), -glc 
Ginsenoside Re -H -O-glc2- 1rha 20(S), -glc 
Ginsenoside Rg1 -H -O-glc 20(S), -glc 
Ginsenoside Rg2 -H -O-glc2- 1rha 20(S), -H 
20R-ginsenoside Rg2 -H -O-glc2- 1rha 20(R), -H 
Ginsenoside Rg3 -glc2- 1glc -H 20(S), -H 
Ginsenoside Rh1 -H -O-glc 20(S), -H 
Ginsenoside Rh2 -glc -H 20(S), -H 
Fig. 1. Chemical structures of assayed ginsenosides in American ginseng.  
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Ginsenoside Rg3 increased significantly from 0.5 to 3 h of steaming. Ginsenoside Rh2 is also 
an active anticancer saponin, however, after steaming treatment, the content of Rh2 was 
very low (Table 1).  
 
Ginsenoside 
Asian 
Ginseng 
Red Asian
Ginseng 
American
Ginseng 
Steaming Time (Red American Ginseng) 
0.5 h 1 h 2 h 3 h 4 h 
Rg1 0.279 0.276 0.133 0.098 0.075 0.017 ND ND 
Re 0.234 0.188 1.750 1.347 0.968 0.221 0.032 ND 
Rh1 ND 0.015 ND 0.008 0.017 0.040 0.042 0.049 
Rg2 0.031 0.034 0.015 0.154 0.266 0.405 0.444 0.363 
20R-Rg2 ND 0.022 ND 0.086 0.155 0.388 0.425 0.422 
Rb1 0.545 0.462 4.940 3.918 3.252 1.743 0.735 0.177 
Rc 0.523 0.294 0.387 0.325 0.278 0.141 0.087 0.018 
Rb2 0.443 0.200 0.043 0.042 0.036 0.026 0.018 ND 
Rb3 0.067 0.032 0.063 0.064 0.050 0.035 0.017 ND 
Rd 0.257 0.073 0.604 0.510 0.460 0.335 0.206 0.097 
Rg3 0.004 0.033 0.003 0.143 0.271 0.664 1.053 1.225 
Rh2 ND 0.009 0.007 0.007 0.018 0.047 0.057 0.066 
Total 2.38 1.64 7.95 6.70 5.85 4.05 3.11 2.42 
n = 3; ND, not detected; values are expressed as percentage of dry weight; RSD (relative standard 
derivation) are less than 15%. 
Table 1. Ginsenoside contents in Asian ginseng, red Asian ginseng and American ginseng 
which were unsteamed or steamed at 120°C for 0.5-4 h. 
2.4 Cell culture 
The human breast cancer cell lines MCF-7 and MDA-MB-231 were purchased from 
American Type Culture Collection, ATCC (Manassas, VA, USA) and grown in RPMI 1640 
medium supplemented with 10% FBS and 50 IU penicillin/streptomycin in a humidified 
atmosphere of 5% CO2 at 37°C.  
2.5 Cell proliferation analysis 
Cells were seeded in 96-well plates. After 1 d, various concentrations of 
extracts/ginsenosides were added to the wells. The final concentration of ethanol was 0.5%. 
Controls were exposed to culture medium containing 0.5% ethanol without drugs. All 
experiments were performed in triplicate and repeated 3 times. Cell proliferation was 
evaluated using an MTS assay according to the manufacturer’s instructions. Briefly, at the 
end of the drug exposure period, the medium was replaced with 100 μl of fresh medium, 20 
μl of MTS reagent (CellTiter 96 Aqueous Solution) in each well, and the plate was returned 
to the incubator for 1-2 h. A 60-μl aliquot of medium from each well was transferred to an 
ELISA 96-well plate and its absorbance at 490 nm was recorded 4,18. Results were expressed 
as percentage of control (ethanol vehicles set at 100%).  
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2.6 Apoptosis assay 
Cells were seeded in 24-well tissue culture plates. After culturing for 1 day, the medium was 
changed and extracts/ginsenosides were added. After treated for 48 h, cells floating in the 
medium were collected. The adherent cells were detached with 0.05% trypsin. Then culture 
medium containing 10% FBS (and floating cells) was added to inactivate trypsin. After being 
pipetted gently, the cells were centrifuged for 5 min at 1500 g. The supernatant was 
removed and cells were stained with annexin V-FITC and propidium iodide according to 
the manufacturer’s instructions. Untreated cells were used as control for double staining. 
Cells were analyzed immediately after staining using a FACScan flow cytometer (Becton 
Dickinson, Mountain View, CA) and FlowJo 7.1.0 software (Tree Star, Ashland, OR). For 
each measurement, at least 20,000 cells were counted.  
2.7 Cyclin A and cyclin D1 assay 
Cells were seeded in 24-well tissue culture plates. On the second day, the medium was 
changed and cells were treated with extracts. Cells were incubated for 48 h before the cells 
were harvested. The cells were fixed gently by putting 80% ethanol in freezer for 2 h and 
were then treated with 0.25% Triton X-100 for 5 min on ice bath. Cells were resuspended in 
300 ul of PBS containing 40 µg/ml propidium iodide and 0.1 mg/ml RNase. Then, 20 µl of 
cyclin A-FITC or cyclin D1-FITC was added to the cell suspension. Then the cells were 
incubated in a dark room for 20 min at room temperature, and analyzed with a FACScan 
flow cytometer. For each measurement, at least 20,000 cells were counted.  
2.8 Cell cycle assay 
After cells were treated with extracts/ginsenosides, the cells were harvested in similar 
manner to the method used in the cyclins assay. Then, the cells were stained with 
propidium iodide, and analyzed with a FACScan flow cytometer. For each measurement, at 
least 20,000 cells were counted.  
2.9 Statistical analysis 
Data are presented as mean ± standard deviation (SD) with n = 3. A one-way ANOVA 
determined whether the results had statistical significance. In some cases, Student's t-test 
was used for comparing two groups. The level of statistical significance was set at P<0.05.  
3. Results 
3.1 Saponin composition changes in extracts during heat-processing 
Twelve ginsenosides (Figure 1) were determined in American ginseng using high 
performance liquid chromatography (HPLC). All the assayed ginsenosides were 
dammarane glycosides 17,19. The influence of steaming at 100°C and 120°C on the 
ginsenoside content of American ginseng was tested. Compared with unsteamed American 
ginseng, the roots treated at 100°C for 1 h decreased total ginsenoside content slightly, from 
7.95% to 7.32%. For the main saponin contents, ginsenoside Rb1 was changed from 4.940% 
to 4.463%, and Re was from 1.756% to 1.630%; ginsenoside Rg3 increased from 0.003% to 
0.048%. Steaming at 120°C for 1 h decreased the total ginsenoside content to 5.85%, as 
follows: Rb1, 3.252%; Re, 0.968%; and Rg3, 0.271%. Ginsenoside Rg3 increased significantly 
at 120°C.  
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Chromatograms of unsteamed and steamed American ginseng roots for 2 and 4 h at 120°C 
are shown in Figure 2. The peak areas of Rb1, Rd and Re decreased during the steaming 
process. On the other hand, ginsenoside Rg3, which is a trace saponin in unsteamed root 17, 
was augmented during the steaming process (Figure 3). The content of the 12 ginsenosides 
in steamed American ginseng roots is shown in Table 1. During the steaming process, Rg1, 
Re, Rb1, Rc, Rb2, Rb3, and Rd decreased; Rh1, Rg2, 20R-Rg2, Rg3 and Rh2 increased.  
 
 
Fig. 2. HPLC analysis of ginsenosides in unsteamed and steamed American ginseng roots. 
Chromatograms of unsteamed (A), or steamed at 120°C for 2 h (B) and 4 h (C) are shown. 
Ginsenoside peaks: (1) Rg1, (2) Re, (3) Rh1, (4) Rg2, (5) 20R-Rg2, (6) Rb1, (7) Rc, (8) Rb2, (9) 
Rb3, (10) Rd, (11) Rg3, (12) Rh2. Peak numbers are not shown if saponins were not detected. 
The chemical constituents of white ginseng and red ginseng (P. ginseng C. A. Meyer) were 
also determined. Data shown in Table 1 indicated that for the Asian ginseng, after steaming 
at 100°C, the contents of the main ginsenosides (Rg1, Re, Rb1, Rb2, Rc and Rd) were 
decreased. Ginsenoside Rg3 increased from 0.004% to 0.033%. The changes of ginsenoside 
contents are similar to that of American ginseng steamed at 100°C. 
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Fig. 3. Saponin content in American ginseng roots steamed at 120 °C for 0-4 h. The content of 
six major ginsenosides was changed during the steaming process. 
3.2 Antiproliferative effects of extracts and ginsenosides on human breast cancer 
cells 
Using two human breast cancer cell lines MCF-7 and MDA-MB-231, the antiproliferative 
effect of unsteamed and steamed American ginseng root extracts were evaluated. For the 
MCF-7 cells, at 0.25 mg/ml, unsteamed extract inhibited cell growth by 17.0%. After 
steaming for 1 h, the extract inhibited cell growth by 60.0% (P<0.01 vs. unsteamed extract). 
Moreover, after cells treated with 2 h steamed extract, cell growth was inhibited absolutely. 
At 0.5 mg/ml, extracts from 1 h and 2 h steamed roots inhibited cell growth over 99.6% 
(Figure 4A). For the MDA-MB-231 cells, at 0.25 mg/ml, extracts from unsteamed and 1 h 
steamed roots did not show a antiproliferative effect, while extract from 2 h steamed roots 
showed a very strong effect, as cell growth was inhibited by 99.2% (Figure 4B). These results 
suggested that steaming on American ginseng roots increased antiproliferative effects on 
human breast cancer cells, and the effects of extract from root steamed for 2 h were more 
potent than that of root steamed for 1 h.  
Four representative ginsenosides were used to test for antiproliferative effects on breast 
cancer cells. Among them, two ginsenosides (Rb1 and Re) were major constituents in 
unsteamed American ginseng roots, while two other ginsenosides (Rg2 and Rg3) were main 
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constituents in steamed roots. At 30-300 μM, after 72 h treatment, ginsenosides Rb1, Re and 
Rg2 did not show antiproliferative effects on MCF-7 and MDA-MB-231 cells. Ginsenoside 
Rg3 showed positive antiproliferative effect on both the cancer cell lines. At 100 μM, 
ginsenoside Rg3 inhibited cell growth by 49.8% on MCF-7 cells, and by 27.3% on MDA-MB-
231 cells (both P<0.01 vs. untreated control). At 300 μM, ginsenoside Rg3 almost inhibited 
cell growth on both the cell lines absolutely (Figure 4C and 4D).  
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Fig. 4. Effects of American ginseng extracts and ginsenosides on proliferation of MCF-7 (A, 
C) and MDA-MB-231 (B, D) human breast cancer cells. Cells were treated with extracts (A, 
B) or ginsenosides (C, D) for 72 h, and then assayed by MTS method. #, P<0.01 vs. 
unsteamed extract; **, P<0.01 vs. control.  
3.3 Apoptotic effect of extracts and ginsenosides on MCF-7 cells 
Apoptosis and necrosis were evaluated in MCF-7 cells using annexin V-FITC, which detects 
translocation of phosphatidylinositol from the inner to outer cell membrane during early 
apoptosis, and propidium iodide, which can enter the cell in late apoptosis or necrosis. As 
shown in Figure 5, compared to untreated control (early apoptosis 5.7%, late 
apoptosis/necrosis 6.1%), after treatment with 0.25 mg/ml for 48 h, unsteamed extract 
increased early apoptosis to 10.3%, but did not influence late apoptosis/necrosis (5.2%). 
After treatment with extract from 2 h steamed roots, early apoptosis increased slightly 
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(7.6%), and late apoptosis/necrosis increased significantly to 37.2%. Since early apoptosis is 
considered real apoptosis, steamed extract did not show obviously activity on early 
apoptosis. For the viable cells, the control was 88.1%, unsteamed extract was 83.8%, while 2 
h steamed extract was 41.5%. Steamed extract significantly decrease the viable cells.  
The effects of induction of apoptosis of representative ginsenosides on MCF-7 cells were 
also determined. Compared to control (5.5%), after treatment with 100-300 μM of 
ginsenosides Rb1 and Rg3 for 48 h, the percentage of early apoptotic cells were not 
increased (less than 6.2% and 5.8%, respectively). At the concentration of 300 μM, 
ginsenoside Re and Rg2 increased the cell percentage of early apoptosis to 13.0% and 9.1%, 
respectively. Consider both the apoptosis effects of steamed extract and its major 
ginsenosides Rb1 and Rg3, the MCF-7 cell growth inhibition activity of steamed extract may 
not be caused by the induction of apoptosis.  
 
 
Fig. 5. Apoptosis assay using flow cytometry after annexin V-FITC/propidium iodide (PI) 
staining. MCF-7 cells were treated with 0.1 and 0.25 mg/ml of unsteamed and 2 h steamed 
extract for 48 h. Viable cells are in lower left quadrant, early apoptotic cells are in lower right 
quadrant, late apoptotic or necrotic cells are in upper right quadrant, and non-viable cells 
which underwent necrosis are in upper left quadrant.  
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3.4 Effect of extracts on the expression of cyclins on MCF-7 cells 
The protein expression of cyclin A and cyclin D1 were evaluated by flow cytometry after 
staining with cyclin A-FITC and cyclin D1-FITC. For the percentage of cyclin A positive 
cells, the untreated control was 56.0%. After treatment with 0.1 and 0.25 mg/ml unsteamed 
extract for 48 h, the cyclin A positive cells were increased to 62.5% and 65.8%, while treated 
with 0.1 and 0.2 mg/ml 2 h steamed extract, cyclin A positive cells were decreased to 48.4% 
and 14.5%, respectively (Figure 6A). For cyclin D1, unsteamed extract did not influence the 
expression of cyclin D1, while 2 h steamed extract decreased the expression of cyclin D1 
significantly (Figure 6B). Cyclin A and cyclin D1 are important cell cycle regulation proteins. 
Steamed extract decreased the expression of both cyclins, suggesting that the inhibition of 
cell growth of steamed extract may caused by the influences of cell cycle.  
 
 
Fig. 6. Cyclins A and D1 analysis of MCF-7 cells using flow cytometry. After treated for 48 h, 
MCF-7 cells were stained with cyclin A-FITC/PI (A) and cyclin D1/PI (B). Isotype: 
untreated cells were stained with isotype antibody/PI. The percentage of cyclin A (A) and 
cyclin D1 (B) positive cells is shown in the gate.  
3.5 Effects of extracts and ginsenosides on MCF-7 cell cycle 
After treatment with unsteamed and steamed extract for 48 h, cells were stained with 
propidium iodide (PI) and then assayed by flow cytometry. Unsteamed extract did not 
influence the cell cycle profile (Figure 7). Compared to untreated control (G1, 68.2%), 0.2 
mg/ml 2 h steamed extract increased the percentage of cells in G1 phase to 83.6%. For the 
single compounds, ginsenosides Rb1, Re and Rg2 almost did not influence the cell cycle. 
Ginsenoside Rg3, a previously recognized anticancer compound, increased the G1 fraction 
to 87.4% (Figure 7). Data from this study suggests that both the 2 h steamed extract and 
ginsenoside Rg3 arrested MCF-7 cells in G1 phase.  
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Fig. 7. Effects of extracts and ginsenosides on cell cycle. After MCF-7 cells were treated with 
extracts or ginsenosides for 48 h, the cells were stained with PI and assayed using flow 
cytometry. The percentage of cells in G1, S and G2/M phases are indicated.  
4. Discussion 
Herbal medicines are comprised of a complicated mixture of biologically active compounds. 
The concentrations of these compounds may vary significantly depending on many intrinsic 
and extrinsic factors such as genetics, season, geographical distribution, plant growth, and 
production and extract processes 20. Thus, herbal medicine identification and analysis are 
very important issues in the quality assurance of herbal products. Since American ginseng 
from Wisconsin is a reliable ginseng source 21, in this study, the American ginseng used was 
from Roland Ginseng, LLC (Wausau, WI). The plant material was identified according to the 
United States Pharmacopoeia NF 21, monograph: American ginseng (Panax quinquefolius L.). 
The contents of major ginsenosides in different American ginseng extracts were determined 
using HPLC, which means that our American ginseng extracts were standardized and the 
quantitative assay data are critical references for future studies.  
Heat-processing on American ginseng changes the constituent profiles. We have reported 
the steaming temperatures and times on the changes of ginsenosides in the crude herb 22. In 
this study, the contents of main ginsenosides in the extracts were evaluated. In unsteamed 
extract, the content of ginsenoside Rb1 was 34.2%, and the summary of six ginsenosides 
were 63.9%. The content of total ginsenoside in extract was very high, suggesting that the 
extraction and purification method used in this study are reasonable.  
Ginsenoside Rg3, a previously recognized anticancer compound 7, was detected in the 
unsteamed and steamed extracts. In unsteamed extract, Rg3 was only a trace saponin 
(0.06%). After 2 h steaming, the content of Rg3 was increased to 5.9%, becoming a main 
constituent in the extract. Therefore, steaming on American ginseng increased Rg3 content 
significantly.  
Pharmacological studies showed that heat-processing on American ginseng increases the 
antiproliferative effect significantly. The biological effects of extracts were based on their 
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chemical constituents. We consequently evaluated the antiproliferative activities of 
representative ginsenosides on human breast cancer cells. Using both cancer cell lines (MCF-
7 and MDA-MB-231), ginsenosides Rb1 and Re, taken from unsteamed extract almost had 
no effect at the concentration range of 30-300 uM. Ginsenoside Rg3, which was taken from 
steamed extract, showed strong antiproliferative activity. The increase of antiproliferative 
effect of steam-processing is based on the increase of anticancer constituents.  
Apoptosis is considered an important pathway in the inhibition of cancer cells of many 
anticancer agents 23,24. In this study, we assayed the induction of apoptosis by American 
ginseng extracts and single compounds. However, the apoptotic induction activities on 
MCF-7 cells were not confirmed by current data. The antiproliferative effect of red American 
ginseng extract on human breast cancer cells may be caused by other mechanisms.  
Recent studies found that overexpression of cyclin D1 promotes tumor cell growth, and 
confers resistance of chemotherapy 23,24. Cyclins assay found that American ginseng extracts 
regulated the expression of cyclin A and cyclin D1 on MCF-7 cells. Red American ginseng 
extract decreased the expression of cyclin A and cyclin D1 significantly. Since cyclins are 
important regulation proteins in cell cycle, we assayed the influence of extract on cell cycle. 
Data showed that red American ginseng extract arrested cells in G1 phase, and decrease the 
percentage of cells in S and G2/M phases. We subsequently studied the influence of 
representative saponins on the cell cycle. Treatment with 100 μM of ginsenosides Rb1, Re 
and Rg2 for 48 h, did not influence the cell cycle profile. Ginsenoside Rg3, a main 
constituent in red American ginseng, arrested cells in G1 phase. This result is similar to that 
of red American ginseng extract.  
At the concentration of 0.25 mg/ml, 2 h steamed extract inhibited cell growth absolutely. 
The 0.25 mg/ml 2 h steamed extract contains 18.6 μM of ginsenoside Rg3. However, even 30 
μM of ginsenoside Rg3 did not show significant antiproliferative activity. From the HPLC 
chromatogram of 2 h steamed extract, several peaks of unidentified compounds can be 
found. We expected that other more potent compounds existed in red American ginseng 
extract, and these compounds have similar effects to Rg3 on cell cycle. This should be focus 
of future studies.  
In summary, analytical and pharmacological data obtained from our observations suggest 
that steamed American ginseng root significantly augments the content of ginsenoside Rg3 
and other unidentified active compounds, which is responsible for the increase in anticancer 
activity. Red American ginseng, which is the heat-processed root of P. quinquefolius, may be 
a potent anti-breast cancer herbal medicine. 
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